Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function

Pediatric Nephrology

Volumn 27, Issue 7, 2012, Pages 1131-1138

  Bacchetta, Justine ^a,b,c   Cochat, Pierre ^a,b   Salusky, Isidro B ^c   Wesseling Perry, Katherine ^c  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Children; FGF23; Growth; IGF1; Inulin clearance; Uric acid

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; PHOSPHORUS; SOMATOMEDIN C; URIC ACID; VITAMIN D;

AGE DISTRIBUTION; ARTICLE; BODY MASS; CALCIUM METABOLISM; CHILD; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PHOSPHATE METABOLISM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; SCHOOL CHILD; SECONDARY ANALYSIS; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL;

CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; KIDNEY FUNCTION TESTS; MALE; RENAL INSUFFICIENCY, CHRONIC; URIC ACID;

EID: 84863986359     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2110-3     Document Type: Article

References (43)

1. Liu S, Quarles LD (2007) How fibroblast growth factor 23 works. J Am Soc Nephrol 18:1637-1647 (Pubitemid 46870300)
2. Yamazaki Y, Tamada T, Kasai N, Urakawa I, Aono Y, Hasegawa H, Fujita T, Kuroki R, Yamashita T, Fukumoto S, Shimada T (2008) Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 23:1509-1518
3. Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Sue-mune S, Kozai K, Tanne K, Aubin JE, Maeda N (2007) Mineralized tissue cells are a principal source of FGF23. Bone 40:1565-1573 (Pubitemid 46756409)
4. Fukumoto S (2008) Physiological regulation and disorders of phosphate metabolism\-pivotal role of fibroblast growth factor 23. Intern Med 47:337-343 (Pubitemid 351663682)
5. Razzaque MS (2009) Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant 24:4-7
6. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003-4008 (Pubitemid 350224109)
7. Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, Juppner H (2010) Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab 95:578-585
8. Lafage-Proust MH (2010) Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients? Kidney Int 77:390-392
9. Juppner H, Wolf M, Salusky IB (2010) FGF23: more than a regulator of renal phosphate handling? J Bone Miner Res 25:2091-2097
10. Prie D, Urena Torres P, Friedlander G (2009) Latest findings in phosphate homeostasis. Kidney Int 75:882-889
11. Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutierrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305:2432-2439
12. Mirza MA, Hansen T, Johansson L, Ahlstrom H, Larsson A, Lind L, Larsson TE (2009) Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transplant 24:3125-3131
13. Mirza MA, Larsson A, Lind L, Larsson TE (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205:385-390
14. Kazama JJ, Sato F, Omori K, Hama H, Yamamoto S, Maruyama H, Narita I, Gejyo F, Yamashita T, Fukumoto S, Fukagawa M (2005) Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int 67:1120-1125 (Pubitemid 41623338)
15. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584-592
16. Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M (2005) Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int 67:1171-1178 (Pubitemid 41623344)
17. Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, Brewer ED (2011) Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Neph-rol 26:945-951
18. Bacchetta J, Dubourg L, Harambat J, Ranchin B, Abou-Jaoude P, Arnaud S, Carlier MC, Richard M, Cochat P (2010) The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. J Clin Endocrinol Metab 95:1741-1748
19. Wesseling-Perry K, Pereira R, Tseng C, Elashoff R, Zaritsky J, Yadin O, Sahney S, Gales B, Juppner H, Salusky IB (2012) Abnormalities in skeletal mineralisation and increased FGF23 levels: early manifestations of pediatric renal osteodystrophy. Clin J Am Soc Nephrol 7:146-152
20. Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370-1378
21. Sempe M (1997) Auxologie: méthode et séquences. Méditions, Paris
22. Matos V, van Melle G, Boulat O, Markert M, Bachmann C, Guignard JP (1997) Urinary phosphate/creatinine, calcium/creati-nine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr 131:252-257 (Pubitemid 27495246)
23. Adams JS, Hewison M (2010) Update in vitamin D. J Clin Endo-crinol Metab 95:471-478
24. Ardeshirpour L, Cole DE, Carpenter TO (2007) Evaluation of bone and mineral disorders. Pediatr Endocrinol Rev 5(Suppl 1):584-598
25. Ibrahim S, Rashed L (2009) Serum fibroblast growth factor-23 levels in chronic haemodialysis patients. Int Urol Nephrol 41:163-169
26. So A, Thorens B (2010) Uric acid transport and disease. J Clin Invest 120:1791-1799
27. Fam AG (2005) Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet. J Rheumatol 32:773-777 (Pubitemid 40676482)
28. Stapleton FB, Linshaw MA, Hassanein K, Gruskin AB (1978) Uric acid excretion in normal children. J Pediatr 92:911-914 (Pubitemid 8323926)
29. Helvig CF, Cuerrier D, Hosfield CM, Ireland B, Kharebov AZ, Kim JW, Ramjit NJ, Ryder K, Tabash SP, Herzenberg AM, Epps TM, Petkovich M (2010) Dysregulation of renal vitamin D metabolism in the uremic rat. Kidney Int 78:463-472
30. Gutierrez OM, Wolf M, Taylor EN (2011) Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol 6:2871-2878
31. Ishay A, Herer P, Luboshitzky R (2011) Effects of successful para-thyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism. Endocr Pract 17:584-590
32. Kobayashi K, Imanishi Y, Miyauchi A, Onoda N, Kawata T, Tahara H, Goto H, Miki T, Ishimura E, Sugimoto T, Ishikawa T, Inaba M, Nishizawa Y (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93-99 (Pubitemid 43250742)
33. Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, Nishizawa Y (2007) Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroid-ism. J Am Soc Nephrol 18:2683-2688 (Pubitemid 47531195)
34. Laspa E, Bastepe M, Juppner H, Tsatsoulis A (2004) Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance. J Clin Endocrinol Metab 89:5942-5947 (Pubitemid 39628397)
35. Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T (2010) PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 299:F882-F889
36. Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Juppner H, Salusky IB (2009) Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 94:511-517
37. Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91:3144-3149 (Pubitemid 44271770)
38. Seikaly MG, Salhab N, Warady BA, Stablein D (2007) Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS. Pediatr Nephrol 22:1195-1204
39. Ito N, Fukumoto S, Taguchi M, Takeshita A, Takeuchi Y, Yamada S, Fujita T (2007) Fibroblast growth factor (FGF)23 in patients with acromegaly. Endocr J 54:481-484 (Pubitemid 47105439)
40. Kuro-o M (2010) Klotho. Pflugers Arch 459:333-343
41. Cancela AL, Oliveira RB, Graciolli FG, dos Reis LM, Barreto F, Barreto DV, Cuppari L, Jorgetti V, Carvalho AB, Canziani ME, Moyses RM (2011) Fibroblast growth factor 23 in he-modialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron Clin Pract 117:c74-c82
42. Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM (2010) Circulating Levels of Soluble Klotho and FGF23 in X-Linked Hypophosphate-mia: Circadian Variance, Effects of Treatment and Relationship to Parathyroid Status. J Clin Endocrinol Metab 95:352-357
43. Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, Hasegawa H, Yamashita T, Nakatani K, Saito Y, Okamoto N, Kurumatani N, Namba N, Kitaoka T, Ozono K, Sakai T, Hataya H, Ichikawa S, Imel EA, Econs MJ, Nabeshima Y (2010) Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 398:513-518